by October Gallery
FRANKFURT (Reuters) – Private equity-backed generic drugmaker Stada STAGn.D said it has agreed to buy 15 consumer healthcare products from British drugmaker GlaxoSmithKline (GSK.L) to further strengthen its prescription-free drugs…
(Reuters) – Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.…
(Reuters) – GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out of three previous treatment options, in a boost for the…
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain’s largest drugmaker…
(Reuters) – British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded $89.7…
LONDON (Reuters) – A long-acting injection developed by GlaxoSmithKline (GSK.L) and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects…
LONDON (Reuters) – GlaxoSmithKline’s new research boss aims to turbo-charge the British group’s drug discovery engine with a $300 million bet on genetics by buying a stake in the Silicon…
LONDON (Reuters) – GlaxoSmithKline is facing “unprecedented” demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analysts initially thought. The…
(Reuters) – GlaxoSmithKline’s two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the…